Biomarkers in Alzheimer's disease: What are they and how can they help?
The diagnosis, staging, prognosis, and treatment plan for individuals with Alzheimer’s disease has lagged behind the precision seen for other medical illness. However, our field is on the verge of a major revision of its assessment tools which will allow for greater precision based on biological markers of Alzheimer’s disease. In this presentation, you will learn what the current and future biomarkers for this disease consist of and the role that biomarkers will play in decision making for patients and their physicians.
Location:Women's College Hospital - 76 Grenville Street, Toronto ON M5S 1B2
PARKING/TRANSIT
Street Parking is available in the area around Women's College Hospital on Grosvenor Street and underground parking is available at the hospital (enter on Grenville Street). Both require payment. Subway Access is via Queen's Park on the University Line or College Park on the Yonge Line.
Cost: $10
Agenda:
5:30pm - Registration
6:00pm to 7:30pm - Lecture
Presented by Toronto Memory Program
Dr. Sharon Cohen is a Canadian-trained behavioural neurologist. She is the medical director and site principal investigator at Toronto Memory Program. She is known for her excellence in patient care, teaching and clinical research. She holds an FRCPC in neurology from the Royal College of Physicians and Surgeons of Canada. For the past 25 years, Dr. Cohen has been committed to improving treatment for Alzheimer’s and related disorders. Her memory clinic and research site are among the most active in Canada and have provided care and clinical trial opportunities to thousands of individuals.
Presented by: Toronto Memory Program ![]() |